Income Statement (TTM)
BeOne Medicines AG - Depositary Receipt (Common Stock) Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 266 | 309 | 863 | 947 | 1,062 | 1,176 | 877 | 1,069 | 1,250 | 1,416 | 1,557 | 1,811 | 15,649 | 2,459 | 2,763 | 3,097 | 23,508 | 3,810 | 4,176 | 4,562 |
| Change (%) | 16.26 | 179.30 | 9.78 | 12.18 | 10.72 | -25.44 | 21.84 | 16.96 | 13.29 | 9.97 | 16.29 | 764.19 | -84.29 | 12.36 | 12.09 | 659.16 | -83.79 | 9.60 | 9.25 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1,290 | 1,366 | 1,400 | 1,493 | 1,522 | 279 | 1,726 | 1,783 | 1,886 | 286 | 52 | -440 | -6,279 | 380 | 423 | 1,380 | 3,838 | 594 | 634 | 752 |
| Change (%) | 5.84 | 2.56 | 6.57 | 1.95 | -81.65 | 518.01 | 3.30 | 5.81 | -84.81 | -81.69 | -939.26 | 1,326.11 | -106.05 | 11.36 | 226.26 | 178.05 | -84.52 | 6.74 | 18.63 | |
| % of Revenue | 485.63 | 442.10 | 162.34 | 157.60 | 143.23 | 23.74 | 196.79 | 166.84 | 150.94 | 20.23 | 3.37 | -24.31 | -40.12 | 15.45 | 15.31 | 44.58 | 16.33 | 15.59 | 15.19 | 16.49 |
| Gross Operating Profit | -1,024 | -1,057 | -538 | -546 | -459 | 897 | -849 | -714 | -637 | 1,129 | 1,505 | 2,251 | 21,928 | 2,079 | 2,340 | 1,716 | 19,670 | 3,216 | 3,542 | 3,810 |
| Change (%) | 3.14 | -49.10 | 1.44 | -15.80 | -295.29 | -194.63 | -15.85 | -10.87 | -277.40 | 33.22 | 49.61 | 874.10 | -90.52 | 12.54 | -26.64 | 1,046.10 | -83.65 | 10.12 | 7.57 | |
| % of Revenue | -385.63 | -342.10 | -62.34 | -57.60 | -43.23 | 76.26 | -96.79 | -66.84 | -50.94 | 79.77 | 96.63 | 124.31 | 140.12 | 84.55 | 84.69 | 55.42 | 83.67 | 84.41 | 84.81 | 83.51 |
| SG&A | 535 | 600 | 675 | 783 | 892 | 990 | 1,104 | 1,203 | 1,257 | 1,279 | 1,313 | 1,376 | 10,238 | 1,509 | 1,608 | 1,656 | 12,221 | 1,832 | 1,864 | 1,958 |
| Change (%) | 12.12 | 12.50 | 16.03 | 13.84 | 11.02 | 11.52 | 8.98 | 4.46 | 1.72 | 2.66 | 4.85 | 643.92 | -85.26 | 6.56 | 3.03 | 637.76 | -85.01 | 1.74 | 5.05 | |
| % of Revenue | 201.50 | 194.31 | 78.27 | 82.72 | 83.94 | 84.17 | 125.90 | 112.60 | 100.57 | 90.30 | 84.30 | 76.00 | 65.42 | 61.36 | 58.20 | 53.49 | 51.99 | 48.08 | 44.63 | 42.92 |
| R&D | 1,345 | 1,641 | 1,910 | 2,472 | 21,148 | 1,779 | 1,831 | 947 | 13,464 | 1,953 | 1,975 | 1,953 | ||||||||
| Change (%) | 16.41 | 29.43 | 755.53 | -91.59 | 2.93 | -48.26 | 1,321.43 | -85.49 | 1.09 | -1.08 | ||||||||||
| % of Revenue | 114.33 | 115.86 | 122.65 | 136.51 | 135.14 | 72.34 | 66.26 | 30.59 | 57.28 | 51.26 | 47.28 | 42.82 | ||||||||
| OpEx | 1,826 | 1,967 | 2,076 | 2,277 | 2,414 | 2,615 | 2,831 | 2,987 | 3,144 | 3,206 | 3,276 | 3,409 | 24,939 | 3,667 | 3,861 | 3,984 | 29,726 | 4,379 | 4,472 | 4,664 |
| Change (%) | 7.67 | 5.59 | 9.65 | 6.04 | 8.31 | 8.25 | 5.52 | 5.26 | 1.95 | 2.18 | 4.06 | 631.65 | -85.29 | 5.29 | 3.17 | 646.20 | -85.27 | 2.13 | 4.27 | |
| % of Revenue | 687.51 | 636.69 | 240.70 | 240.41 | 227.25 | 222.31 | 322.77 | 279.51 | 251.57 | 226.40 | 210.36 | 188.24 | 159.37 | 149.15 | 139.77 | 128.65 | 126.45 | 114.93 | 107.10 | 102.23 |
| Operating Income | -1,561 | -1,658 | -1,214 | -1,330 | -1,352 | -1,439 | -1,954 | -1,918 | -1,894 | -1,790 | -1,718 | -1,598 | -9,290 | -1,209 | -1,099 | -887 | -6,218 | -569 | -297 | -102 |
| Change (%) | 6.21 | -26.78 | 9.55 | 1.67 | 6.42 | 35.80 | -1.81 | -1.25 | -5.53 | -3.98 | -7.02 | 481.45 | -86.99 | -9.09 | -19.26 | 600.97 | -90.85 | -47.88 | -65.77 | |
| % of Revenue | -587.51 | -536.69 | -140.70 | -140.41 | -127.25 | -122.31 | -222.77 | -179.51 | -151.57 | -126.40 | -110.36 | -88.24 | -59.37 | -49.15 | -39.77 | -28.65 | -26.45 | -14.93 | -7.10 | -2.23 |
| Interest Expense | -16 | -18 | -21 | -29 | -27 | -28 | -26 | -23 | -21 | -19 | -19 | -19 | -79 | -4 | -3 | -4 | -108 | -15 | -19 | -22 |
| Change (%) | 9.53 | 14.58 | 39.93 | -6.31 | 4.49 | -9.21 | -10.46 | -9.88 | -7.56 | -0.09 | -1.78 | 323.53 | -94.67 | -24.47 | 14.34 | 2,848.75 | -86.32 | 25.83 | 16.57 | |
| % of Revenue | -6.18 | -5.82 | -2.39 | -3.04 | -2.54 | -2.40 | -2.92 | -2.15 | -1.65 | -1.35 | -1.23 | -1.04 | -0.51 | -0.17 | -0.12 | -0.12 | -0.46 | -0.39 | -0.44 | -0.47 |
| Net Income | -1,512 | -1,625 | -1,167 | -1,327 | -1,340 | -1,458 | -1,960 | -2,030 | -2,149 | -2,004 | -1,917 | -1,732 | -7,128 | -882 | -784 | -524 | -5,993 | -645 | -392 | -178 |
| Change (%) | 7.46 | -28.20 | 13.74 | 0.97 | 8.80 | 34.41 | 3.58 | 5.88 | -6.76 | -4.33 | -9.63 | 311.41 | -87.63 | -11.03 | -33.24 | 1,044.43 | -89.24 | -39.15 | -54.73 | |
| % of Revenue | -569.22 | -526.10 | -135.24 | -140.12 | -126.12 | -123.93 | -223.42 | -189.94 | -171.96 | -141.52 | -123.12 | -95.67 | -45.55 | -35.86 | -28.39 | -16.91 | -25.50 | -16.92 | -9.40 | -3.89 |
Source: Capital IQ
